This morning, Crystal Research CEO Jeff Kraws spoke with Reuters' Rhonda Schaffler about winners and losers of today's landmark Supreme Court ruling upholding Obamacare's individual mandate. Mr. Kraws discussed specific stocks to watch as well as sector trends for healthcare insurers, hospitals, pharma and biotech companies, medical records, medical schools, generics, and medical device companies, among others.

Tune in live at 11:45 am this morning to Reuters Insider for an overview of the landmark healthcare ruling and its impact on your investments....recap to follow here.

On June 21, 2012, Crystal Research issued a Quarterly Update on LRAD Corp. (LRAD-NASDAQ), a company developing and marketing acoustic hailing devices (AHD) that support the delivery and intelligibility of audio broadcasts over long ranges. The 12-page Update is available here.

New research available in our library at www.crystalra.com gives readers a complete description of the business of AtheroNova: its product development, milestones, competitive pressures, market opportunities, risks, and more. A 52-page report is available here, with future Quarterly Updates coming as AtheroNova advances this year.